Literature DB >> 16632674

Cardiac disease and Rett syndrome.

M Acampa1, F Guideri.   

Abstract

Rett syndrome (RS) is a neurodevelopmental disease,1 affecting approximately 1 in 10 000-15 000 females. Clinical severity of RS may vary with increasing age, following a four stage model.

Entities:  

Mesh：

Year:  2006        PMID： 16632674      PMCID： PMC2082747          DOI： 10.1136/adc.2005.090290

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  31 in total

Review 1.  Central cardiovascular regulation and 5-hydroxytryptamine receptors.

Authors:  A G Ramage
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

2.  [Tachyarrhythmia as the first manifestation in a classic Rett syndrome].

Authors:  S I Panossian; E A Duro
Journal:  Rev Neurol       Date:  2004 Aug 1-15       Impact factor: 0.870

3.  Substance P immunoreactivity in Rett syndrome.

Authors:  K Deguchi; B A Antalffy; L J Twohill; S Chakraborty; D G Glaze; D D Armstrong
Journal:  Pediatr Neurol       Date:  2000-04       Impact factor: 3.372

4.  Forensic issues and possible mechanisms of sudden death in Rett syndrome.

Authors:  Roger W Byard
Journal:  J Clin Forensic Med       Date:  2005-11-02

5.  Cardiac dysautonomia and serotonin plasma levels in Rett syndrome.

Authors:  F Guideri; M Acampa; P Blardi; A de Lalla; M Zappella; Y Hayek
Journal:  Neuropediatrics       Date:  2004-02       Impact factor: 1.947

6.  Rett's syndrome in the west of Scotland.

Authors:  A M Kerr; J B Stephenson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

Review 7.  Rett Syndrome -- an update.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2003-06       Impact factor: 3.575

8.  Sudden unexpected death in children and adolescents.

Authors:  D J Driscoll; W D Edwards
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

9.  Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome.

Authors:  F Guideri; M Acampa; G Calamandrei; L Aloe; M Zappella; Y Hayek
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

10.  Severe sinus bradycardia in a patient with Rett syndrome: a new cause for a pause?

Authors:  N Madan; M Levine; K Pourmoghadam; M Sokoloski
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655
View more
  12 in total

1.  Preliminary Evidence That Resting State Heart Rate Variability Predicts Reactivity to Tactile Stimuli in Rett Syndrome.

Authors:  Alyssa M Merbler; Breanne J Byiers; John Hoch; Adele C Dimian; Chantel C Barney; Timothy J Feyma; Arthur A Beisang; Alessandro Bartolomucci; Frank J Symons
Journal:  J Child Neurol       Date:  2019-09-25       Impact factor: 1.987

Review 2.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

Review 3.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

4.  Evaluation of QTc in Rett syndrome: Correlation with age, severity, and genotype.

Authors:  Jane Crosson; Siddharth Srivastava; Genila M Bibat; Siddharth Gupta; Aditi Kantipuly; Constance Smith-Hicks; Scott M Myers; Abanti Sanyal; Gayane Yenokyan; Joel Brenner; Sakkubai R Naidu
Journal:  Am J Med Genet A       Date:  2017-04-10       Impact factor: 2.802

5.  Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome.

Authors:  Thomas Ladas; Shyue-An Chan; Michael Ogier; Corey Smith; David M Katz
Journal:  Eur J Neurosci       Date:  2009-08-07       Impact factor: 3.386

6.  Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias.

Authors:  Munetsugu Hara; Tomoyuki Takahashi; Chiaki Mitsumasu; Sachiyo Igata; Makoto Takano; Tomoko Minami; Hideo Yasukawa; Satoko Okayama; Keiichiro Nakamura; Yasunori Okabe; Eiichiro Tanaka; Genzou Takemura; Ken-ichiro Kosai; Yushiro Yamashita; Toyojiro Matsuishi
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

7.  Inflammatory lung disease in Rett syndrome.

Authors:  Claudio De Felice; Marcello Rossi; Silvia Leoncini; Glauco Chisci; Cinzia Signorini; Giuseppina Lonetti; Laura Vannuccini; Donatella Spina; Alessandro Ginori; Ingrid Iacona; Alessio Cortelazzo; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Tommaso Pizzorusso; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-03-17       Impact factor: 4.711

8.  Alterations in the carnitine cycle in a mouse model of Rett syndrome.

Authors:  Sabrina Mucerino; Anna Di Salle; Nicola Alessio; Sabrina Margarucci; Raffaella Nicolai; Mariarosa A B Melone; Umberto Galderisi; Gianfranco Peluso
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

9.  Anesthetic management of a Rett syndrome patient with apnea and epilepsy: a case report.

Authors:  Yuka Motomura; Masafumi Idei; Hitoshi Sato; Takahisa Goto
Journal:  JA Clin Rep       Date:  2018-04-18

10.  Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome.

Authors:  Silvia Maffei; Claudio De Felice; Pierpaolo Cannarile; Silvia Leoncini; Cinzia Signorini; Alessandra Pecorelli; Barbara Montomoli; Stefano Lunghetti; Lucia Ciccoli; Thierry Durand; Roberto Favilli; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-01-12       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.